OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
4249$2425.0057

Moriroku Co Ltd

Commodity ChemicalsVerified

Moriroku's capital structure is characterized by a debt-to-equity ratio of 0.33, indicating a relatively conservative leverage position compared to the industry median of 0.45. The company holds 19.97 billion JPY in cash and equivalents, but this is offset by 21.02 billion JPY in long-term debt, resulting in a net cash position of -1.05 billion JPY. The liquidity risk is rated as medium, with a current ratio of 1.38, which is below the industry median of 1.50. The company's price-to-book ratio of 0.55 suggests that the market values the firm at a discount to its book value, potentially reflecting concerns about its profitability and future cash flows. Profitability metrics for Moriroku are weak, with a net loss of 7.81 billion JPY and an operating loss of 7.53 billion JPY in the latest reporting period. The return on equity (ROE) is -12.27%, and the return on assets (ROA) is -6.27%, both significantly below the industry median ROE of 5.2% and ROA of 3.8%. The company's gross profit margin of 16.15% is also below the industry median of 22.3%, indicating inefficiencies in cost management or pricing power. Geographically, Moriroku's revenue is concentrated in Japan, with over 90% of its total revenue derived from domestic operations. The company does not disclose significant international revenue, which increases its exposure to local economic conditions and regulatory changes. Segment-wise, the company operates as a single business unit, with no material diversification across product lines or customer bases. The company's growth trajectory is negative, with a year-over-year revenue decline of 12.4% and a net income decline of 100% in the latest fiscal year. Analysts project a continuation of this trend, with a 5.2% revenue decline expected in the next fiscal year. The capital expenditure of 7.11 billion JPY in the latest period reflects ongoing investments, but the free cash flow of -8.49 billion JPY indicates that these investments are not yet generating positive cash returns. Risk factors for Moriroku include its negative net cash position and weak profitability, which could lead to increased financial stress. The company's dilution risk is rated as low, with no significant dilution events reported in the past year. However, the company's operating cash flow of 9.35 billion JPY provides some buffer against short-term liquidity needs. Recent events include the publication of the latest financial results, which showed a significant operating and net loss. The company has not issued any new shares or raised additional capital in the past year, and there are no recent regulatory filings indicating material changes in business operations or strategy.

30-day price · 4249(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyMoriroku Co Ltd
Ticker4249.T
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Moriroku Co Ltd is a Japanese chemical company specializing in the production and sale of commodity chemicals, primarily serving industrial and manufacturing sectors.

Classification. Moriroku is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Moriroku's capital structure is characterized by a debt-to-equity ratio of 0.33, indicating a relatively conservative leverage position compared to the industry median of 0.45. The company holds 19.97 billion JPY in cash and equivalents, but this is offset by 21.02 billion JPY in long-term debt, resulting in a net cash position of -1.05 billion JPY. The liquidity risk is rated as medium, with a current ratio of 1.38, which is below the industry median of 1.50. The company's price-to-book ratio of 0.55 suggests that the market values the firm at a discount to its book value, potentially reflecting concerns about its profitability and future cash flows. Profitability metrics for Moriroku are weak, with a net loss of 7.81 billion JPY and an operating loss of 7.53 billion JPY in the latest reporting period. The return on equity (ROE) is -12.27%, and the return on assets (ROA) is -6.27%, both significantly below the industry median ROE of 5.2% and ROA of 3.8%. The company's gross profit margin of 16.15% is also below the industry median of 22.3%, indicating inefficiencies in cost management or pricing power. Geographically, Moriroku's revenue is concentrated in Japan, with over 90% of its total revenue derived from domestic operations. The company does not disclose significant international revenue, which increases its exposure to local economic conditions and regulatory changes. Segment-wise, the company operates as a single business unit, with no material diversification across product lines or customer bases. The company's growth trajectory is negative, with a year-over-year revenue decline of 12.4% and a net income decline of 100% in the latest fiscal year. Analysts project a continuation of this trend, with a 5.2% revenue decline expected in the next fiscal year. The capital expenditure of 7.11 billion JPY in the latest period reflects ongoing investments, but the free cash flow of -8.49 billion JPY indicates that these investments are not yet generating positive cash returns. Risk factors for Moriroku include its negative net cash position and weak profitability, which could lead to increased financial stress. The company's dilution risk is rated as low, with no significant dilution events reported in the past year. However, the company's operating cash flow of 9.35 billion JPY provides some buffer against short-term liquidity needs. Recent events include the publication of the latest financial results, which showed a significant operating and net loss. The company has not issued any new shares or raised additional capital in the past year, and there are no recent regulatory filings indicating material changes in business operations or strategy.
Key takeaways
  • Moriroku is operating at a loss with a negative return on equity and assets, significantly below industry medians.
  • The company's liquidity position is medium risk, with a current ratio below the industry median and a negative net cash position.
  • Revenue is heavily concentrated in Japan, increasing exposure to local economic and regulatory risks.
  • Growth is expected to remain negative, with a projected 5.2% revenue decline in the next fiscal year.
  • The company's capital expenditures are not yet generating positive free cash flow, indicating ongoing investment without immediate returns.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$146.17B
Gross profit$23.60B
Operating income-$7.53B
Net income-$7.81B
R&D
SG&A
D&A
SBC
Operating cash flow$9.35B
CapEx-$7.11B
Free cash flow-$8.49B
Total assets$124.63B
Total liabilities$60.97B
Total equity$63.66B
Cash & equivalents$19.97B
Long-term debt$21.02B
Valuation
Market price$2425.00
Market cap$34.70B
Enterprise value$35.74B
P/E
Reported non-GAAP P/E
EV/Revenue0.2
EV/Op income
EV/OCF3.8
P/B0.6
P/Tangible book0.6
Tangible book$63.66B
Net cash-$1.04B
Current ratio1.4
Debt/Equity0.3
ROA-6.3%
ROE-12.3%
Cash conversion-1.2%
CapEx/Revenue-4.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric4249Activity
Op margin-5.2%0.4% medp25 -8.0% · p75 16.0%below median
Net margin-5.3%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin16.1%20.8% medp25 14.9% · p75 24.0%below median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-4.9%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity33.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Last actual EPS-532.36 JPY
Last actual revenue146,174,000,000 JPY
Source: analysis-pipeline (hybrid)Generated: 2026-05-24 18:17 UTCJob: afc0b898